A recent study carried out on human GBM cells, using a new antimetastatic drug called ascochlorin (ASC), showed downregulation of MMP-2 activity and FAK signaling pathway, resulting in decreased cell migration and invasion [55]. Here, PTK2 is linked to glioblastoma.